Antidepressant-like effect of the extracted of Kai Xin San, a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in mouse
- PMID: 22138350
- DOI: 10.1016/j.jep.2011.11.027
Antidepressant-like effect of the extracted of Kai Xin San, a traditional Chinese herbal prescription, is explained by modulation of the central monoaminergic neurotransmitter system in mouse
Abstract
Ethnopharmacological relevance: Kai Xin San (KXS) is a traditional Chinese herbal prescription for the treatment of depression-like disorders, anxiety, and impairment in learning and memory, however, there is very little scientific data concerning the efficacy of this.
Aim of the study: The present study aimed to investigate the antidepressant potential of Kai Xin San and its possible mechanisms.
Materials and methods: Mouse models of depression including the tail suspension test (TST) and the forced swim test (FST) were used to evaluate the effects of KXS. A possible mechanism was explored in the tests of antagonism of reserpine-induced ptosis, akinesia and hypothermia and 5-HTP induced head-twitch response in mice. The contents of monoamine neurotransmitters including epinephrine (NE), 5-hydroxytryptamine (5-HT) and dopamine (DA) in mice brain were determined by Elisa. Spontaneous motor activities of mice and rotarod test were performed to find whether KXS has excitatory or inhibitory actions on the central nervous system.
Results: The results showed that intragastric administration of KXS at 175, 350, 700, 1400 mg/kg/day or fluoxetine at 28 mg/kg/day for 3 days significantly reduced the duration of immobility in TST and FST, while it showed no effect on the spontaneous motor activity and rotarod performance in mice. However, the effect was not dose-dependent. The pre-treatment with KXS or fluoxetine for 3 days could elevate the contents of NE, 5-HT and DA in mice brain significantly. When the mice were treated with KXS (350 mg/kg, p.o) or desipramine (30 mg/kg, p.o) for 7 days, both of them could antagonize reserpine-induced ptosis, akinesia and hypothermia. The KXS (350 mg/kg) also increased the accumulative number of the 5-HTP-induced head twitch response in mice in 20 min when KXS at dosages of 175, 350, 700 and 1400 mg/kg/day were performed per os (p.o.) during a 1-day, 3-day or 7-day period.
Conclusions: Our results suggested that KXS exerts antidepressant-like effect. A possible mechanism, at least in part, is via the central monoaminergic neurotransmitter system and 5-HT plays a major role.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice.J Ethnopharmacol. 2013 Jul 9;148(2):603-9. doi: 10.1016/j.jep.2013.05.011. Epub 2013 May 20. J Ethnopharmacol. 2013. PMID: 23702040
-
Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.J Ethnopharmacol. 2012 May 7;141(1):257-64. doi: 10.1016/j.jep.2012.02.026. Epub 2012 Feb 17. J Ethnopharmacol. 2012. PMID: 22366432
-
On the mechanism of antidepressant-like action of berberine chloride.Eur J Pharmacol. 2008 Jul 28;589(1-3):163-72. doi: 10.1016/j.ejphar.2008.05.043. Epub 2008 Jun 3. Eur J Pharmacol. 2008. PMID: 18585703
-
Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors.Curr Drug Targets. 2009 Nov;10(11):1069-84. doi: 10.2174/138945009789735156. Curr Drug Targets. 2009. PMID: 19702555 Review.
-
Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders.Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2;38(1):78-87. doi: 10.1016/j.pnpbp.2011.11.007. Epub 2011 Nov 23. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22133541 Review.
Cited by
-
Constituents, pharmacological activities, pharmacokinetic studies, clinical applications, and safety profile on the classical prescription Kaixinsan.Front Pharmacol. 2024 Feb 1;15:1338024. doi: 10.3389/fphar.2024.1338024. eCollection 2024. Front Pharmacol. 2024. PMID: 38362144 Free PMC article. Review.
-
MiR-1281 is involved in depression disorder and the antidepressant effects of Kai-Xin-San by targeting ADCY1 and DVL1.Heliyon. 2023 Mar 7;9(3):e14265. doi: 10.1016/j.heliyon.2023.e14265. eCollection 2023 Mar. Heliyon. 2023. PMID: 36938448 Free PMC article.
-
Systematic review of Kaixinsan in treating depression: Efficacy and pharmacological mechanisms.Front Behav Neurosci. 2022 Dec 6;16:1061877. doi: 10.3389/fnbeh.2022.1061877. eCollection 2022. Front Behav Neurosci. 2022. PMID: 36560929 Free PMC article.
-
Kai-Xin-San Protects Depression Mice Against CORT-Induced Neuronal Injury by Inhibiting Microglia Activation and Oxidative Stress.Evid Based Complement Alternat Med. 2022 Oct 19;2022:5845800. doi: 10.1155/2022/5845800. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36310618 Free PMC article.
-
Antidepressant Mechanism of Kaixinsan and Its Active Compounds Based on Upregulation of Antioxidant Thioredoxin.Evid Based Complement Alternat Med. 2022 Jul 19;2022:7302442. doi: 10.1155/2022/7302442. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35911169 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
